Effects of TEAS on POCD
Effects of Transcutanclus Electrical Acupoint Stimulation on Postoperative Cognitive Dysfunction in Elderly Patients
1 other identifier
interventional
110
1 country
1
Brief Summary
Patients undergoing elective orthopedics, urology, and general surgery will be included and randomly allocated to TEAS group or control group . After routine anesthesia induction and tracheal intubation, patients in TEAS group will receive electrical stimulation of acupoints at Neiguan and Shenmen points. For patients in the control group, the electrodes will be only attached to the corresponding sites, with no TEAS electrical stimulation given during the operation. The primary outcome is the incidence of POCD at Day 7 after surgery. The secondary outcomes include the incidence of POD during post-operative days 1-7, the incidence of POCD at Day 30 after surgery, and the serum levels of cytokines, including IL-1β、IL-6、TNF-α、MMP9 on Day 1 after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2020
CompletedFirst Posted
Study publicly available on registry
April 8, 2020
CompletedStudy Start
First participant enrolled
October 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 26, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 26, 2022
CompletedJuly 3, 2024
July 1, 2024
1 year
April 6, 2020
July 2, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
the incidence of POCD
cognitive function of the patients will be analyzed with MMSE, Digital breadth, Number symbol, Visual regeneration, Color word conversion, Color Trail Marking Test (PartB) and CAM, and reflected by Z score with the following formula: Z=(Xafter-Xbefore)/SDbefore
at Day 7 post-surgery
Secondary Outcomes (6)
the incidence of POCD
at Day 30 post-surgery
the incidence of delirium
from Day 1 to Day 7 post-surgery
serum IL-1β level
at Day 1 post-surgery
serum IL-6 level
at Day 1 post-surgery
serum TNF-α level
at Day 1 post-surgery
- +1 more secondary outcomes
Study Arms (2)
TEAS group
EXPERIMENTALPatients in the TEAS group will receive electrical stimulation of acupoints at Neiguan and Shenmen points for 30min every hour. The stimulation will repeat until the end of surgery.
control group
NO INTERVENTIONIn patients from the control group, the electrodes will only be attached to the corresponding sites, with no TEAS electrical stimulation given during the operation.
Interventions
TEAS group will receive electrical stimulation of acupoints at Neiguan and Shenmen points for 30 min every hour during the surgery.
Eligibility Criteria
You may qualify if:
- ≧ 60 years old;
- communicate normally;
- ASA Physical Status 1-2;
- Patients will have elective orthopedics, urology or general surgeries under general anesthesia;
- With an estimated surgery time of more than 2h;
- Agree to participate the trial.
You may not qualify if:
- Patients with brain diseases or history of brain diseases;
- Preoperative diagnosis of cognitive impairment by subtle mental state (MMSE) less than 24 points;
- Patients with history of neurological and psychological disorders including AD, stroke, and psychosis;
- Severe hearing or visual impairment, illiteracy;
- preoperative systolic blood pressure \>190mmHg, or diastolic blood pressure \>100mmHg;
- Disagree to participate in this research;
- Have used other medical electronic devices.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RenJi Hospitallead
Study Sites (1)
Renji Hospital
Shanghai, 200127, China
Study Officials
- PRINCIPAL INVESTIGATOR
Jie Tian
RenJi Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
April 6, 2020
First Posted
April 8, 2020
Study Start
October 14, 2021
Primary Completion
October 26, 2022
Study Completion
October 26, 2022
Last Updated
July 3, 2024
Record last verified: 2024-07